Mike Doustdar, Business Leaders
Novo Nordisk CEO Faces Turnaround Pressure Amid Board Overhaul, Pfizer Rivalry
50% center coverage2 sources
Mike Doustdar
United States Politics
Discover the latest news, candidates, and key topics of US politics
Latest News
Mike Doustdar, Business Leaders
Novo Nordisk CEO Faces Turnaround Pressure Amid Board Overhaul, Pfizer Rivalry
50% center coverage2 sources
Mike Doustdar, Nutrition
India sees sixfold surge in weight-loss drug demand amid misuse concerns
100% center coverage1 source
Mike Doustdar, Nutrition
India sees sixfold surge in weight-loss drug demand amid misuse concerns
100% center coverage1 source
Mike Doustdar, Business Leaders
Novo Nordisk Cuts 9,000 Jobs Globally Amid Weight-Loss Drug Competition
50% center coverage2 sources
Mike Doustdar, Business Leaders
Novo Nordisk Cuts 9,000 Jobs Globally Amid Weight-Loss Drug Competition
50% center coverage2 sources
Mike Doustdar, Nutrition
Novo Nordisk's Largest Investor Seizes Board Control Amid Market Struggles
100% left coverage1 source
Mike Doustdar, Nutrition
Novo Nordisk's Largest Investor Seizes Board Control Amid Market Struggles
100% left coverage1 source
Mike Doustdar, Markets
Novo Nordisk Foundation Plans Board Overhaul Amid $70 Billion Market Cap Loss
50% left coverage2 sources
Mike Doustdar, Markets
Novo Nordisk Foundation Plans Board Overhaul Amid $70 Billion Market Cap Loss
50% left coverage2 sources
Mike Doustdar
Novo Nordisk Cuts 9,000 Jobs Amid Global Obesity Drug Competition
50% center coverage2 sources
Mike Doustdar
Novo Nordisk Cuts 9,000 Jobs Amid Global Obesity Drug Competition
50% center coverage2 sources
Mike Doustdar, Startups
Novo Nordisk Signs $550M RNA Partnership With Replicate Bioscience
100% left coverage1 source
Mike Doustdar, Startups
Novo Nordisk Signs $550M RNA Partnership With Replicate Bioscience
100% left coverage1 source
United States Politics
Discover the latest news, candidates, and key topics of US politics
Most Reported By
News from Mike Doustdar
News from Mike Doustdar